In the last 12 months, insiders at PALVELLA THERAPEUTICS, INC. ($PVLA) filed 80 transactions with the SEC: 10 open-market purchases totaling $1,094,818 and 10 sales totaling $2,055,146. Net insider sentiment: net selling.
PALVELLA THERAPEUTICS, INC. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Goin Kathleen (Chief Operating Officer) — 34 transactions totaling $2,229,563
- JENKINS GEORGE M (Director) — 7 transactions totaling $702,491
- HERON ELAINE J (Director) — 3 transactions totaling $300,000
- ADAR1 Capital Management, LLC (TenPercentOwner) — 3 transactions totaling $92,326
- GERAGHTY JAMES A (Director) — 2 transactions totaling $1
View all SEC Filings for PALVELLA THERAPEUTICS, INC. (PVLA).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 30, 2026 | JENKINS GEORGE M | Director | P | Common Stock | 445 | $112.30 | 201,132.0000 | 11,836,490 | 0.22% | 0.00% |
| March 18, 2026 | Goin Kathleen | Chief Operating Officer | M | Common Stock | 2154 | $7.14 | 2,154.0000 | 11,836,490 | 9999.99% | 0.02% |
| March 18, 2026 | Goin Kathleen | Chief Operating Officer | M | Stock Option (Right to Buy) | 2148 | $0.00 | 15,036.0000 | 11,836,490 | 12.50% | 0.02% |
| March 18, 2026 | Goin Kathleen | Chief Operating Officer | M | Stock Option (Right to Buy) | 2154 | $0.00 | 15,089.0000 | 11,836,490 | 12.49% | 0.02% |
| March 18, 2026 | Goin Kathleen | Chief Operating Officer | S | Common Stock | 304 | $119.08 | 0.0000 | 11,836,490 | 100.00% | 0.00% |
| March 18, 2026 | Goin Kathleen | Chief Operating Officer | S | Common Stock | 1730 | $118.37 | 304.0000 | 11,836,490 | 85.05% | 0.01% |
| March 18, 2026 | Goin Kathleen | Chief Operating Officer | S | Common Stock | 2268 | $117.56 | 2,034.0000 | 11,836,490 | 52.72% | 0.02% |
| March 18, 2026 | Goin Kathleen | Chief Operating Officer | M | Common Stock | 2148 | $9.08 | 4,302.0000 | 11,836,490 | 99.72% | 0.02% |
| Feb. 27, 2026 | JENKINS GEORGE M | Director | P | Common Stock | 4000 | $125.00 | 200,687.0000 | 11,836,490 | 2.03% | 0.03% |
| Feb. 27, 2026 | HERON ELAINE J | Director | P | Common Stock | 2400 | $125.00 | 53,691.0000 | 11,836,490 | 4.68% | 0.02% |
| Feb. 18, 2026 | Goin Kathleen | Chief Operating Officer | M | Common Stock | 2148 | $9.08 | 4,302.0000 | 11,836,490 | 99.72% | 0.02% |
| Feb. 18, 2026 | Goin Kathleen | Chief Operating Officer | M | Common Stock | 2154 | $7.14 | 2,154.0000 | 11,836,490 | 9999.99% | 0.02% |
| Feb. 18, 2026 | Goin Kathleen | Chief Operating Officer | M | Stock Option (Right to Buy) | 2148 | $0.00 | 17,184.0000 | 11,836,490 | 11.11% | 0.02% |
| Feb. 18, 2026 | Goin Kathleen | Chief Operating Officer | M | Stock Option (Right to Buy) | 2154 | $0.00 | 17,243.0000 | 11,836,490 | 11.10% | 0.02% |
| Feb. 18, 2026 | Goin Kathleen | Chief Operating Officer | S | Common Stock | 1276 | $79.97 | 0.0000 | 11,836,490 | 100.00% | 0.01% |
| Feb. 18, 2026 | Goin Kathleen | Chief Operating Officer | S | Common Stock | 3026 | $79.16 | 1,276.0000 | 11,836,490 | 70.34% | 0.03% |
| Feb. 5, 2026 | Goin Kathleen | Chief Operating Officer | A | Stock Option (Right to Buy) | 48956 | $0.00 | 48,956.0000 | 11,836,490 | 9999.99% | 0.41% |
| Feb. 5, 2026 | Kaupinen Wes | President and CEO | A | Stock Option (Right to Buy) | 124603 | $0.00 | 124,603.0000 | 11,836,490 | 9999.99% | 1.05% |
| Feb. 5, 2026 | Kline Ashley Hartmann | Chief Commercial Officer | A | Stock Option (Right to Buy) | 38517 | $0.00 | 38,517.0000 | 11,836,490 | 9999.99% | 0.33% |
| Feb. 5, 2026 | Martini Jeffrey S | Chief Scientific Officer | A | Stock Option (Right to Buy) | 64318 | $0.00 | 64,318.0000 | 11,836,490 | 9999.99% | 0.54% |
| Feb. 5, 2026 | Korenberg Matthew E | CFO, Treasurer | A | Stock Option (Right to Buy) | 44123 | $0.00 | 44,123.0000 | 11,836,490 | 9999.99% | 0.37% |
| Jan. 21, 2026 | Goin Kathleen | Chief Operating Officer | M | Stock Option (Right to Buy) | 2154 | $0.00 | 19,397.0000 | 11,836,490 | 9.99% | 0.02% |
| Jan. 21, 2026 | Goin Kathleen | Chief Operating Officer | M | Stock Option (Right to Buy) | 2148 | $0.00 | 19,332.0000 | 11,836,490 | 10.00% | 0.02% |
| Jan. 21, 2026 | Goin Kathleen | Chief Operating Officer | S | Common Stock | 3749 | $97.94 | 0.0000 | 11,836,490 | 100.00% | 0.03% |
| Jan. 21, 2026 | Goin Kathleen | Chief Operating Officer | S | Common Stock | 553 | $95.49 | 3,749.0000 | 11,836,490 | 12.85% | 0.00% |
| Jan. 21, 2026 | Goin Kathleen | Chief Operating Officer | M | Common Stock | 2148 | $9.08 | 4,302.0000 | 11,836,490 | 99.72% | 0.02% |
| Jan. 21, 2026 | Goin Kathleen | Chief Operating Officer | M | Common Stock | 2154 | $7.14 | 2,154.0000 | 11,836,490 | 9999.99% | 0.02% |
| Dec. 17, 2025 | Goin Kathleen | Chief Operating Officer | S | Common Stock | 4302 | $96.47 | 0.0000 | 11,836,490 | 100.00% | 0.04% |
| Dec. 17, 2025 | Goin Kathleen | Chief Operating Officer | M | Common Stock | 2154 | $7.14 | 2,154.0000 | 11,836,490 | 9999.99% | 0.02% |
| Dec. 17, 2025 | Goin Kathleen | Chief Operating Officer | M | Common Stock | 2148 | $9.08 | 4,302.0000 | 11,836,490 | 99.72% | 0.02% |
| Dec. 17, 2025 | Goin Kathleen | Chief Operating Officer | M | Stock Option (Right to Buy) | 2154 | $0.00 | 21,551.0000 | 11,836,490 | 9.09% | 0.02% |
| Dec. 17, 2025 | Goin Kathleen | Chief Operating Officer | M | Stock Option (Right to Buy) | 2148 | $0.00 | 21,480.0000 | 11,836,490 | 9.09% | 0.02% |
| Nov. 19, 2025 | Goin Kathleen | Chief Operating Officer | S | Common Stock | 2802 | $86.51 | 0.0000 | 11,836,490 | 100.00% | 0.02% |
| Nov. 19, 2025 | Goin Kathleen | Chief Operating Officer | M | Stock Option (Right to Buy) | 2148 | $0.00 | 23,628.0000 | 11,836,490 | 8.33% | 0.02% |
| Nov. 19, 2025 | Goin Kathleen | Chief Operating Officer | M | Stock Option (Right to Buy) | 2154 | $0.00 | 23,705.0000 | 11,836,490 | 8.33% | 0.02% |
| Nov. 19, 2025 | Goin Kathleen | Chief Operating Officer | M | Common Stock | 2154 | $7.14 | 2,154.0000 | 11,836,490 | 9999.99% | 0.02% |
| Nov. 19, 2025 | Goin Kathleen | Chief Operating Officer | M | Common Stock | 2148 | $9.08 | 4,302.0000 | 11,836,490 | 99.72% | 0.02% |
| Nov. 19, 2025 | Goin Kathleen | Chief Operating Officer | S | Common Stock | 1500 | $85.72 | 2,802.0000 | 11,836,490 | 34.87% | 0.01% |
| June 10, 2025 | Wessel Tadd S. | Director | A | Non-Qualified Stock Option (right to buy) | 12350 | $0.00 | 12,350.0000 | 11,018,747 | 9999.99% | 0.11% |
| June 10, 2025 | Davis Todd C | Director | A | Non-Qualified Stock Option (right to buy) | 12350 | $0.00 | 12,350.0000 | 11,018,747 | 9999.99% | 0.11% |
| June 10, 2025 | KIRITSY CHRISTOPHER P | Director | A | Non-Qualified Stock Option (right to buy) | 12350 | $0.00 | 12,350.0000 | 11,018,747 | 9999.99% | 0.11% |
| June 10, 2025 | HERON ELAINE J | Director | A | Non-Qualified Stock Option (right to buy) | 12350 | $0.00 | 12,350.0000 | 11,018,747 | 9999.99% | 0.11% |
| June 10, 2025 | JENKINS GEORGE M | Director | A | Non-Qualified Stock Option (right to buy) | 12350 | $0.00 | 12,350.0000 | 11,018,747 | 9999.99% | 0.11% |
| May 27, 2025 | Kline Ashley Hartmann | Chief Commercial Officer | A | Non-Qualified Stock Option (right to buy) | 111496 | $0.00 | 111,496.0000 | 11,018,747 | 9999.99% | 1.01% |
| May 27, 2025 | Kline Ashley Hartmann | Chief Commercial Officer | A | Incentive Stock Option (right to buy) | 17436 | $0.00 | 17,436.0000 | 11,018,747 | 9999.99% | 0.16% |
| April 9, 2025 | JENKINS GEORGE M | Director | P | Common Stock | 2500 | $20.13 | 196,687.0000 | 11,018,747 | 1.29% | 0.02% |
| April 9, 2025 | JENKINS GEORGE M | Director | P | Common Stock | 2490 | $20.27 | 196,687.0000 | 11,018,747 | 1.28% | 0.02% |
| Feb. 5, 2025 | Martini Jeffrey S | Chief Scientific Officer | A | Incentive Stock Option (right to buy) | 5373 | $0.00 | 5,373.0000 | 0 | 9999.99% | 0.00% |
| Feb. 5, 2025 | Goin Kathleen | Chief Operating Officer | A | Non-Qualified Stock Option (right to buy) | 123559 | $0.00 | 123,559.0000 | 0 | 9999.99% | 0.00% |
| Feb. 5, 2025 | Korenberg Matthew E | CFO and Treasurer | A | Incentive Stock Option (right to buy) | 5373 | $0.00 | 5,373.0000 | 0 | 9999.99% | 0.00% |
| Feb. 5, 2025 | Martini Jeffrey S | Chief Scientific Officer | A | Non-Qualified Stock Option (right to buy) | 123559 | $0.00 | 123,559.0000 | 0 | 9999.99% | 0.00% |
| Feb. 5, 2025 | Korenberg Matthew E | CFO and Treasurer | A | Non-Qualified Stock Option (right to buy) | 123559 | $0.00 | 123,559.0000 | 0 | 9999.99% | 0.00% |
| Feb. 5, 2025 | Goin Kathleen | Chief Operating Officer | A | Incentive Stock Option (right to buy) | 5373 | $0.00 | 5,373.0000 | 0 | 9999.99% | 0.00% |
| Feb. 5, 2025 | Kaupinen Wes | President and CEO | A | Non-Qualified Stock Option (right to buy) | 243831 | $0.00 | 243,831.0000 | 0 | 9999.99% | 0.00% |
| Feb. 5, 2025 | PALVELLA THERAPEUTICS, INC. | CFO and Treasurer | A | Incentive Stock Option (right to buy) | 5373 | $0.00 | 5,373.0000 | 0 | 9999.99% | 0.00% |
| Feb. 5, 2025 | PALVELLA THERAPEUTICS, INC. | Chief Operating Officer | A | Non-Qualified Stock Option (right to buy) | 123559 | $0.00 | 123,559.0000 | 0 | 9999.99% | 0.00% |
| Feb. 5, 2025 | PALVELLA THERAPEUTICS, INC. | Chief Operating Officer | A | Incentive Stock Option (right to buy) | 5373 | $0.00 | 5,373.0000 | 0 | 9999.99% | 0.00% |
| Feb. 5, 2025 | PALVELLA THERAPEUTICS, INC. | President and CEO | A | Non-Qualified Stock Option (right to buy) | 243831 | $0.00 | 243,831.0000 | 0 | 9999.99% | 0.00% |
| Feb. 5, 2025 | PALVELLA THERAPEUTICS, INC. | CFO and Treasurer | A | Non-Qualified Stock Option (right to buy) | 123559 | $0.00 | 123,559.0000 | 0 | 9999.99% | 0.00% |
| Feb. 5, 2025 | PALVELLA THERAPEUTICS, INC. | Chief Scientific Officer | A | Non-Qualified Stock Option (right to buy) | 123559 | $0.00 | 123,559.0000 | 0 | 9999.99% | 0.00% |
| Feb. 5, 2025 | PALVELLA THERAPEUTICS, INC. | Chief Scientific Officer | A | Incentive Stock Option (right to buy) | 5373 | $0.00 | 5,373.0000 | 0 | 9999.99% | 0.00% |
| Dec. 18, 2024 | JENKINS GEORGE M | Director | P | Common Stock | 4000 | $12.93 | 191,697.0000 | 0 | 2.13% | 0.00% |
| Dec. 13, 2024 | BVF PARTNERS L P/IL | Other | J | Common Stock, $0.001 par value | 29648 | $0.00 | 38,961.0000 | 0 | 318.35% | 0.00% |
| Dec. 13, 2024 | Kaupinen Wes | President and CEO | A | Stock Option (right to buy) | 417806 | $0.00 | 417,806.0000 | 0 | 9999.99% | 0.00% |
| Dec. 13, 2024 | KIRITSY CHRISTOPHER P | Director | A | Stock Option (right to buy) | 24700 | $0.00 | 24,700.0000 | 0 | 9999.99% | 0.00% |
| Dec. 13, 2024 | BVF PARTNERS L P/IL | Other | J | Common Stock, $0.001 par value | 234323 | $0.00 | 371,916.0000 | 0 | 170.30% | 0.00% |
| Dec. 13, 2024 | BVF PARTNERS L P/IL | Other | J | Common Stock, $0.001 par value | 174958 | $0.00 | 282,223.0000 | 0 | 163.11% | 0.00% |
| Dec. 13, 2024 | Wessel Tadd S. | Director | A | Stock Option (right to buy) | 24700 | $0.00 | 24,700.0000 | 0 | 9999.99% | 0.00% |
| Dec. 13, 2024 | HERON ELAINE J | Director | A | Stock Option (right to buy) | 24700 | $0.00 | 24,700.0000 | 0 | 9999.99% | 0.00% |
| Dec. 13, 2024 | Davis Todd C | Director | A | Stock Option (right to buy) | 24700 | $0.00 | 24,700.0000 | 0 | 9999.99% | 0.00% |
| Dec. 13, 2024 | Martini Jeffrey S | Chief Scientific Officer | A | Stock Option (right to buy) | 126416 | $0.00 | 126,416.0000 | 0 | 9999.99% | 0.00% |
| Dec. 13, 2024 | Goin Kathleen | Chief Operating Officer | A | Stock Option (right to buy) | 27843 | $0.00 | 27,843.0000 | 0 | 9999.99% | 0.00% |
| Dec. 13, 2024 | Korenberg Matthew E | CFO, Treasurer | A | Stock Option (right to buy) | 167100 | $0.00 | 167,100.0000 | 0 | 9999.99% | 0.00% |
| Dec. 13, 2024 | JENKINS GEORGE M | Director | A | Stock Option (right to buy) | 24700 | $0.00 | 24,700.0000 | 0 | 9999.99% | 0.00% |
| Dec. 12, 2024 | GERAGHTY JAMES A | Director | D | Series F Preferred Stock, par value $0.001 per share | 1 | $0.01 | 0.0000 | 0 | 100.00% | 0.00% |
| Dec. 2, 2024 | KIRITSY CHRISTOPHER P | Director | A | Stock Option (right to buy) | 500 | $0.00 | 500.0000 | 0 | 9999.99% | 0.00% |
| Aug. 7, 2024 | GERAGHTY JAMES A | Director | P | Series F Preferred Stock, par value $0.001 per share | 1 | $1.00 | 1.0000 | 0 | 9999.99% | 0.00% |
| Aug. 12, 2024 | ADAR1 Capital Management, LLC | TenPercentOwner | P | Common Stock | 757 | $15.88 | 144,641.0000 | 0 | 0.53% | 0.00% |
| Aug. 12, 2024 | ADAR1 Capital Management, LLC | TenPercentOwner | P | Common Stock | 2243 | $15.88 | 144,641.0000 | 0 | 1.58% | 0.00% |
| Aug. 9, 2024 | ADAR1 Capital Management, LLC | TenPercentOwner | P | Common Stock | 3000 | $14.89 | 142,398.0000 | 0 | 2.15% | 0.00% |